Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Nipro Pharma Corporation, based in Japan, is a prominent player in the pharmaceutical preparation manufacturing industry. Headquartered in Japan, the company operates extensively across Asia and other regions, specialising in the development and production of high-quality pharmaceutical solutions. Founded in 1954, Nipro Pharma has established a strong reputation for innovation and reliability within the healthcare sector.
The company’s core offerings include sterile pharmaceutical preparations, medical devices, and related products, distinguished by rigorous quality standards and advanced manufacturing techniques. Recognised for its commitment to patient safety and product excellence, Nipro Pharma holds a notable position in the global pharmaceutical market. Its longstanding history and continuous growth underscore its role as a trusted provider in the pharmaceutical manufacturing industry.
-17 vs industry average
Nipro Pharma Corporation’s score of 25 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Nipro Pharma Corporation yet.
Nipro Pharma Corporation, a Pharmaceutical Preparation Manufacturing company headquartered in Japan, does not have publicly available individual carbon emissions data. Its climate performance data is inherited from its parent company, Nipro Corporation, at a cascade level of 1.
While specific emissions figures for Nipro Pharma Corporation are not available, it is understood that as a subsidiary, its environmental efforts align with those of Nipro Corporation. Further details regarding Nipro Corporation's specific climate commitments, targets, and emissions data would provide a more complete picture of Nipro Pharma Corporation's indirect environmental footprint.
No climate goals have been disclosed for Nipro Pharma Corporation yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more